Early infant diagnosis of HIV infection in low-income and middle-income countries: Does one size fit all?

The Lancet Infectious Diseases

Volumn 14, Issue 7, 2014, Pages 650-655

  Penazzato, Martina ^a   Revill, Paul ^b   Prendergast, Andrew J ^a,c,d   Collins, Intira J ^a   Walker, Simon ^b   Elyanu, Peter J ^e   Sculpher, Mark ^b   Gibb, Diana M ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Zvitambo Institute for Maternal and Child Health Research   (Zimbabwe)

^e MINISTRY OF HEALTH   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ALGORITHM; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT DISEASE; INFECTION PREVENTION; LOWEST INCOME GROUP; MALAWI; NOTE; PREDICTIVE VALUE; PRIORITY JOURNAL; THAILAND; UGANDA; VERTICAL TRANSMISSION; ANTIGEN P24 ASSAY; CHILD HEALTH CARE; DRIED BLOOD SPOT TESTING; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HIV TEST; IMMUNOASSAY; INFANT; INFANT MORTALITY; MIDDLE INCOME COUNTRY; NUCLEIC ACID AMPLIFICATION; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SOCIOECONOMICS; VIRUS TRANSMISSION;

AGE FACTORS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; EARLY DIAGNOSIS; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL;

EID: 84904745535     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70262-7     Document Type: Note

References (52)

1. Global update on HIV treatment 2013: results, impact and opportunities 2013, WHO, World Health Organization, Geneva.
2. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364:1236-1243.
3. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359:2233-2244. CHER Study Team.
4. Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting 2008, WHO, World Health Organization, Geneva.
5. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach: 2010 revision 2010, WHO, World Health Organization, Geneva. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf.
6. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach 2013, WHO, World Health Organization, Geneva.
7. Moodley D, Bobat RA, Coutsoudis A, Coovadia HM Predicting perinatal human immunodeficiency virus infection by antibody patterns. Pediatr Infect Dis J 1995, 14:850-852.
8. Chantry CJ, Cooper ER, Pelton SI, Zorilla C, Hillyer GV, Diaz C Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J 1995, 14:382-387.
9. Gutierrez M Has highly active antiretroviral therapy increased the time to seroreversion in HIV exposed but uninfected children?. Clin Infect Dis 2012, 55:1255-1261.
10. WHO recommendations on the diagnosis of HIV infection in infants and children 2010, WHO, World Health Organization, Geneva.
11. Prendergast A, Cotton M, Gibb DM When should antiretroviral therapy be started for HIV-infected infants in resource-limited settings?. Future HIV Ther 2008, 2:201-208.
12. Global report. UNAIDS report on the global AIDS epidemic UNAIDS, (accessed Dec 8, 2013). http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
13. Chatterjee A, Tripathi S, Gass R, et al. Implementing services for early infant diagnosis (EID) of HIV: a comparative descriptive analysis of national programs in four countries. BMC Public Health 2011, 11:553.
14. Countdown to zero. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 2011, UNAIDS, UNAIDS, Geneva.
15. Everybody's business: strengthening health systems to improve health outcomes: WHO's framework for action 2007, WHO, World Health Organization, Geneva.
16. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddard GL Methods for the economic evaluation of healthcare programmes 2005, Oxford University Press, Oxford.
17. Ciaranello AL, Park JE, Ramirez-Avila L, Freedberg KA, Walensky RP, Leroy V Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med 2011, 9:59.
18. Government of Malawi, Ministry of Health. Quarterly HIV programme report Malawi. HIV Testing and Counseling, Prevention of Mother to Child Transmission, Antiretroviral Therapy. January-April, 2013.
19. Kiyaga C, McConnell I, Narayan V, et al. Uganda's innovative efforts to improve testing, retention, and care of HIV-exposed infants. FRLBE104. 18th International AIDS Conference; Vienna, Austria; July 18-23, 2010.
20. Naiwatanakul T, Voramongkol N, Lolekha R, et al. Uptake of Thailand's national program for early infant HIV diagnosis and infant HIV-infection outcomes, 2007-2010. 19th International AIDS Conference; Washington DC, USA; July 22-27, 2012. Abstract WEPE159.
21. Sirirungsi W, Samleerat T, Ngo-Giang-Huong N, et al. Thailand national program for early infant HIV diagnosis: six-year experience using real-time DNA PCR on dried blood spots. 5th International Workshop on HIV Pediatrics; Kuala Lumpur, Malaysia; June 28-29, 2013. Abstract O_16.
22. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007, 298:1888-1899.
23. Sundaram M, Bhekumusa L. Identification of patient loss-points from testing to treatment initiation among infants tested in Swaziland. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; Cape Town, South Africa; July 19-22, 2009. Abstract MOPDD103.
24. Hsiao NY, Stinson K, Myer L Linkage of HIV-infected infants from diagnosis to antiretroviral therapy services across the Western Cape, South Africa. PLoS One 2013, 8:e55308.
25. Creek T, Tanuri A, Smith M, et al. Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission. Pediatr Infect Dis J 2008, 27:22-26.
26. Tejiokem MC, Faye A, Penda IC, et al. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One 2011, 6:e21840.
27. McCollum ED, Preidis GA, Kabue MM, et al. Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study. PLoS One 2010, 5:e9626.
28. Fergusson P, Tomkins A HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg 2009, 103:541-544.
29. van Griensven J, De Naeyer L, Uwera J, Asiimwe A, Gazille C, Reid T Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care. BMC Pediatr 2008, 8:39.
30. Janssen N, Ndirangu J, Newell ML, Bland RM. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child 201; 95: 414-21.
31. Fayorsey RN, Saito S, Carter RJ, et al. Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries. J Acquir Immune Defic Syndr 2013, 62:e124-e130.
32. Early detection of HIV infection in infants and children. Guidance note on the selection of technology for the early diagnosis of HIV in infants and children: summary of recommendations 2007, WHO, World Health Organisation, Geneva.
33. Lilian RR, Kalk E, Bhowan K, et al. Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age. J Clin Microbiol 2012, 50:2373-2377.
34. Bourne DE, Thompson M, Brody LL, et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS 2009, 23:10-16.
35. Nielsen-Saines K, Watts DH, Veloso VG, et al. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 2012, 366:2368-2379.
36. Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med 2013, 369:1828-1835.
37. Rollins N, Mahy M, Becquet R, Kuhn L, Creek T, Mofenson L Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Transm Infect 2012, 88(suppl 2):i44-i51.
38. Gea T Optimizing entry into care: finding children in need. UNICEF/WHO-sponsored consultation to support development of a programming framework for HIV-related treatment, care and support for HIV infected and -exposed children in resource-constrained settings 2006, UNICEF, New York, and Geneva: World Health Organization.
39. Kankasa C, Carter RJ, Briggs N, et al. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr 2009, 51:202-208.
40. Dube Q, Dow A, Chirambo C, et al. Implementing early infant diagnosis of HIV infection at the primary care level: experiences and challenges in Malawi. Bull World Health Organ 2012, 90:699-704. CHIDEV study team.
41. Sprague C, Black V. Cui bono? ART and PMTCT access and equity for rural women and children in South Africa. TUPE0982. 18th International AIDS Conference; Vienna, Austria; July 18-23, 2010.
42. Marmot M Achieving health equity: from root causes to fair outcomes. Lancet 2007, 370:1153-1163.
43. Kellerman S, Essajee S HIV testing for children in resource-limited settings: what are we waiting for?. PLoS Med 2010, 7:e1000285.
44. Rollins N, Little K, Mzolo S, Horwood C, Newell ML Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS 2007, 21:1341-1347.
45. Binagwaho A, Mugwaneza P, Irakoze AA, et al. Scaling up early infant diagnosis of HIV in Rwanda, 2008-2010. J Public Health Policy 2013, 34:2-16.
46. McCollum ED, Preidis GA, Kabue MM, et al. Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study. PLoS One 2010, 5:e9626.
47. Meyer-Rath G, Violar A, Cotton M. The cost of early vs deferred paediatric antiretroviral treatment in South Africa-a comparative economic analysis of the first year of the CHER trial. THLBB103. 18th International AIDS Conference; Vienna, Austria; July 18-23, 2010.
48. Menzies NA, Homsy J, Chang Pitter JY, et al. Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J 2009, 28:819-825.
49. Collins I, Cairns J, Ngo-Giang-Huong N, et al. (2013) Cost-effectiveness of early infant HIV diagnosis and immediate antiretroviral therapy in HIV-infected children in Thailand (Abstract no. WEAD0103). 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention; Kuala Lumpur, Malaysia; 30 June-3 July, 2013.
50. Battistia R Expanding the scientific basis of health technology assessment: a research agenda for the next decade. Int J Technol Assess Health Care 2006, 22:275-282.
51. Claxton K, Walker S, Palmer S, Sculpher M Appropriate perspectives for healthcare decisions. CHE research paper 54 2010, Centre for Health Economics, University of York, (accessed April 28, 2013). http://www.york.ac.uk/che/pdf/rp54.pdf.
52. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010 2010, WHO, World Health Organization, Geneva.